Supreme Pharmacist System

　　　　 At 10 o’clock in the morning on June 6, 2022, Universe Bio will hold a grand press conference at the Jiangzhou International Conference Center.

　　 Over the past year or so, Universal Bio has held a press conference every three to five, and every time it is a major medical breakthrough or technological innovation.

　　 Because of this, as soon as the news was released, countless reporters from home and abroad swarmed in. Thousands of reporters took up the huge press hall.

　　 Lin Wei, vice president and chief press officer of Universe Bio, hosted the press conference.

　　 Under the attention of countless reporters, Lin Wei said with excitement: “Good morning, all kinds of guests, reporters and friends, and welcome you to participate in the press conference of the world…”

　　 Click! ! !

　　 In the gap between Lin Wei’s speech, the conference hall instantly became an ocean of spotlights.

Lin Wei paused and followed: “Here I want to tell you the good news. Under the leadership of Zhou Wen, the chief scientist of Universe Biology, Lin Ming, the senior engineer, and Academician He Junfeng, the deputy director and chief scientist of the Chinese Academy of Sciences and the Institute of Hepatitis B , And with the continuous efforts of hundreds of other scientific researchers, we have successfully overcome viral hepatitis B!”

　　 The press conference site was a bit silent at first, but the next second, there was a huge buzzing sound.

　　 “What do you mean, is there a new drug?”

　　 “I don’t understand this yet, conquering is healing!”

　　 “It’s impossible, isn’t hepatitis B virus incurable.”

“I do not know……”

　　 Lin Wei gave the reporter more than ten seconds to digest what he had just said, and then explained their research results.

　　 When reporters at the scene learned that this drug will cure nearly 300 million hepatitis B virus patients worldwide, there was a lively discussion.

　　……

　　 The news that the hepatitis B virus was conquered spread all over the world instantly.

　　 Countless hepatitis B patients were naturally very excited when they saw this news.

　　 But some dozens of pharmaceutical companies that are studying new hepatitis B drugs, and even have reached the stage of clinical trials, were suddenly struck by lightning after hearing the news.

　　Especially those 6 pharmaceutical companies that got the data of Huanyu Biologics formula, they spent so much energy to do this, but they all did useless work in the end.

　　……

　　 Inside the inner ring of Kyoto, in a building with a national emblem.

　　 A man with a Chinese character face was reading an internal reference news, and he read the news soon.

　　 A slightly surprised look appeared on his face, and he asked in a deep voice, “Is this news true?”

　　 The confidential secretary who was sorting out the information immediately said respectfully: “Yes, the chief, the experts from the Food and Drug Administration have tested it with DGD technology. It is absolutely true.”

　　 The man with the national character face nodded, his serious face showed a smile, and he smiled: “No wonder you dare to pack your tickets with me, it seems that you have been prepared!”

　　The confidential secretary smiled and said, “Yes! Professor Zhou’s level in the medical field really deserves the word genius.”

It is self-evident how important DGD technology is to pharmaceutical companies. It can be regarded as one of the greatest inventions in the pharmaceutical industry. Such high-precision technology cannot be disclosed by Huanyu Biosciences. It must be obtained from the national level. agree.

　　 The same is true when switching to European and American countries. The technology of European and American companies is not arbitrarily exported to China.

　　 So it is conceivable that when Universe Biosciences proposed the sharing of DGD technology, how fierce the opposition was?

　　 Including many high-level bosses who trust Zhou Wen, they also hold objections.

　　 But Zhou Wen still persuaded a bunch of bigwigs.

　　 Zhou Wen’s reason is very good. DGD technology is important, but if you want to regain the standard of the global pharmaceutical market, relying on DGD technology is far from enough.

　　 First of all, NMPA has always been based on the FDA’s lead, and freezing three feet is not a day’s cold. It is not a day or two to completely reverse this situation.

　　Because there are many interests involved.

If there is interest, there are disputes. Many people are unwilling to leave their comfort zone and explore unknown areas. If they do well, the credit is the leader. If they do not well, or if there is a mistake, the specific manager will be unlucky, so DGD technology The domestic promotion has encountered great resistance.

　　The second and most important point is that European and American countries will definitely not allow the core technology to be implemented by Chinese companies in their own country. Even if the academic community supports it, the advocacy of pharmaceutical companies is useless.

　　 I don’t have to think about it.

　　 Then the problem comes. Even if China’s NMPA adopts the DGD technical standard, if the drugs developed by Universe are to be sold abroad, they still need to go through the time-consuming and lengthy clinical trial procedures again.

　　 Someone may want to say that it is their business that European and American countries are willing to be complacent. If the problem is big, it will be sold in China.

But Zhou Wen can’t wait. His new drug research and development speed is far beyond ordinary people’s imagination. He holds a large number of new drugs in his hand and needs to be marketed. The long clinical trial time has caused the drugs to be unable to resemble cosmeceutical hair restorer, scar cream, and antiseptic. Wrinkle creams are on the market quickly.

　　 And DGD technology is a stepping stone to the European and American pharmaceutical market.

　　 At the speed of Zhou Wen’s drug development, European and American pharmaceutical companies combined are not enough for him.

　　 Therefore, sharing DGD technology with Europe and the United States is not for the convenience of European and American countries, but for himself.

　　 Of course, these ordinary people cannot know.

　　 And the upper-level leaders agreed to Zhou Wen only because of his medical skills.

　　 Zhou Wen’s medical skills have almost reached the point where he is superb. The masters of Chinese medicine are no longer enough to describe him. The elders above and his family members now call him “general doctors”.

　　 Can you imagine the weight of his words?

　　 Therefore, when he patted his chest to assure the leaders that he wanted to earn back the DGD technology, the leaders finally agreed to his proposal.

　　 It seems that Zhou Wen has already prepared a killer!

　　……

　　……

Half a month later ~www.mtlnovel.com~ the “Qingganling Preparation” code-named PD0079 developed by Huanyu Biotechnology, as well as the second-class new drugs of four or five other pharmaceutical companies, became the first batch of DGD technology experimental objects in China. Phase I clinical trial.

　　 It usually takes 3 to 6 months for a phase one clinical trial. After using the DGD technology, it only took one week to complete the trial.

　　 Of course, “Qingganling Preparations” passed the first phase of clinical trials without accident.

　　 Once the news came out, it immediately caused a huge sensation.

　　Countless medical laboratories and pharmaceutical companies are surprised and extremely envious of the efficiency and speed of DGD technology.

　　 The relevant departments of Europe, America, Japan and South Korea have also accelerated the approval of DGD technology.

　　 Soon, John became the second country to adopt DGD technology.

　　 Benzene followed closely behind.

　　 then Germany, Portugal, France, Italy, Russia…

　　 And at this speed like a competition, “Qingganling Preparation” has passed the second phase of clinical trials.

　　Everything is ready to go…

　　

　　Https://

　　 Only one second to remember the address of this site:. Mobile version reading URL: